QL1706/Bevacizumab ± Chemotherapy in Post-ICI Non-Squamous NSCLC
Clinical trial NCT07134413 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07134413
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2027-10-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.